Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Intel Corporation (INTC) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lee who wrote (100911)	3/15/2000 8:22:00 PM
From: Proud_Infidel	Read Replies (1) \| Respond to of 186894

Final OT We are not talking about any remedy whatsoever here. It is patenting gene sequences which are common to us all. Should Albert Einstein have been able to patent E=MC2? Are all naturally occurring events now patentable and therefore profitable? Let's hope it doesn't come to that. BK

To: Steve Lee who wrote (100911)	3/15/2000 11:35:00 PM
From: Dinesh	Read Replies (1) \| Respond to of 186894

OT Steve Nobody has ever had the financial incentive to develop a remedy for a rare genetic illness. Medicine is business: don't spoil it by bringing humanity into it. The gene sequences under question are the common ones. Regards Dinesh